AI Summary & Key Takeaways
AI InsightConclusion: This study found that COVID-19 (+) patients had higher procalcitonin levels, lower lymphocyte and monocyte percentages, and lower monocyte percentages with increasing pressure injury stages.
📌 3 Key Takeaways
Abstract
aim: This study aimed to investigate the relationship between inflammatory markers and pressure injuries in intensive care unit (ICU) patients with and without COVID-19 infection. Material and Method: Conducted as a retrospective case-control study at a single center. This research took place from April 2020 to February 2021 in a city hospital in Istanbul affiliated with the Turkish Ministry of Health. Following the acquisition of ethical approval, the researchers assessed patients’ ICU records and laboratory findings. Results: This study found that the mean age of COVID-19 (+) patients was significantly higher compared to COVID-19 (-) patients. In this study, hypertension and diabetes mellitus were the most prevalent comorbidities in both groups. In the current study, the Braden risk scores of COVID-19 (+) patients were found to be lower compared to those of COVID-19 (-) patients. This study found that COVID-19 (+) patients had higher procalcitonin levels, lower lymphocyte and monocyte percentages. COVID-19 (+) patients had a shorter ICU stay compared to COVID-19 (-) patients. The incidence of stage 1 pressure injuries was higher among COVID-19 (+) patients, while stage 3 pressure injuries and suspected tissue damage were more prevalent among COVID-19 (-) patients. Among COVID-19 (+) patients with stage 4 pressure injuries, monocyte levels were lower compared to those with stage 1- 2 injuries. Conclusion: This study found that COVID-19 (+) patients had higher procalcitonin levels, lower lymphocyte and monocyte percentages, and lower monocyte percentages with increasing pressure injury stages.
Özet
İntroduction: This study aimed to investigate the relationship between inflammatory markers and pressure injuries in intensive care unit (ICU) patients with and without COVID-19 infection. Material and Method: Conducted as a retrospective case-control study at a single center. This research took place from April 2020 to February 2021 in a city hospital in Istanbul affiliated with the Turkish Ministry of Health. Following the acquisition of ethical approval, the researchers assessed patients’ ICU records and laboratory findings. Results: This study found that the mean age of COVID-19 (+) patients was significantly higher compared to COVID-19 (-) patients. In this study, hypertension and diabetes mellitus were the most prevalent comorbidities in both groups. In the current study, the Braden risk scores of COVID-19 (+) patients were found to be lower compared to those of COVID-19 (-) patients. This study found that COVID-19 (+) patients had higher procalcitonin levels, lower lymphocyte and monocyte percentages. COVID-19 (+) patients had a shorter ICU stay compared to COVID-19 (-) patients. The incidence of stage 1 pressure injuries was higher among COVID-19 (+) patients, while stage 3 pressure injuries and suspected tissue damage were more prevalent among COVID-19 (-) patients. Among COVID-19 (+) patients with stage 4 pressure injuries, monocyte levels were lower compared to those with stage 1- 2 injuries. Conclusion: This study found that COVID-19 (+) patients had higher procalcitonin levels, lower lymphocyte and monocyte percentages, and lower monocyte percentages with increasing pressure injury stages. Keywords: Pressure injury, COVID-19, infection, Braden risk score, infection parameters